Cross-sectional study reports blood pressure monitoring rates for wearable devices among Chinese adults, indicating digital health disparities.
Aims This study aims to investigate the ownership of wearable health devices across different demographic groups and usage patterns among Chinese Adults. Methods This was a cross-sectional study, with all data originating from the Huawei Blood Pressure Health Study (Huawei-BPHS), a real-world study aimed at exploring blood pressure management through wearable devices in China. Data were remotely collected using mobile phones and Huawei watch D from February 23, 2022, to March 31, 2024. The system utilized artificial intelligence algorithms to assess participants’ risk of hypertension and provided risk alarm feedback via mobile phones and watches. Results A total of 75,918 participants from 31 provinces were included, with an average age of 47 years old. Most of the participants were concentrated in the economically developed South China and East China regions. Among the participants, 73.8% used the watch D for blood pressure monitoring, and 10.5% received risk alerts. The rate of blood pressure monitoring on the day they received the alert was 78%. However, the rate significantly decreased between six months and one year (Mann-Kendall test, Z=-2.85, p<0.05). For hypertensive patients, the blood pressure monitoring rate was 84% on the day they joined the study and decreased over time (Mann-Kendall test, Z=-3.09, p<0.05). However, it remained above 50% within six months. Conclusions This study provides evidence of the digital health divide in the utilization of wearable devices among the Chinese population. Additionally, it proposes a potentially follow-up interval for employing wearable devices for maintaining compliance with blood pressure monitoring.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: